Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report. [electronic resource]
Producer: 20200717Description: 446-447 p. digitalISSN:- 1471-1753
- Adult
- Anti-Bacterial Agents -- therapeutic use
- Antiviral Agents -- therapeutic use
- Betacoronavirus
- COVID-19
- Coronavirus Infections -- complications
- Deprescriptions
- Diabetes Mellitus, Type 2 -- complications
- Drug Combinations
- Drug Therapy, Combination
- Humans
- Hypertension -- complications
- Immunoglobulins, Intravenous -- therapeutic use
- Immunologic Factors -- therapeutic use
- Iran
- Lopinavir -- therapeutic use
- Male
- Mycophenolic Acid -- therapeutic use
- Oseltamivir -- therapeutic use
- Pandemics
- Pemphigoid, Benign Mucous Membrane -- complications
- Pneumonia, Viral -- complications
- Prednisolone -- therapeutic use
- Ritonavir -- therapeutic use
- Rituximab -- therapeutic use
- SARS-CoV-2
- Tomography, Spiral Computed
- COVID-19 Drug Treatment
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.